Analyze Diagnostic Images AI for Healthcare & Life Sciences
Analyze specialized images to identify conditions, anomalies, or diagnostic signals. This comparison covers products mapped to the task specifically in Healthcare & Life Sciences.
Companies collected
36
Products compared
70
Industries observed
19
Market observation
Analyze Diagnostic Images has a distinct market in Healthcare & Life Sciences
This cross-modality ranking reflects supplied evidence, not comparative clinical accuracy. Pricing and deployment proof are sparse. Zero adoption or pricing scores indicate missing supporting evidence, not poor product quality; social following receives only weak weight. Nucleo supplies the clearest named hospital relationships. Buyers should verify intended-use coverage, regulatory scope and clinical validation.
SOTA2 collected 36 companies and 70 products with explicit evidence for this task in Healthcare & Life Sciences. That vertical evidence is what makes this more useful than a general product list.
The products still have to prove task fit, adoption, product maturity, and pricing—the industry label alone does not improve their position.
Evidence-reviewed order
Ranking
We compared 70 products from 36 companies and show the first 10 positions below.
AI-powered dental decision-support tool that reads dental X-rays, detects findings automatically, generates interactive annotations, and suggests pre-filled treatment plans.
Why #2
75/100 evidence score
Automatically detects dental X-ray findings and generates interactive annotations and treatment-plan suggestions. R$130/month pricing and ANVISA certification are listed.
DescriptionPrimary Use CasesPricingCompliance
Task fitStrong
Adoption evidenceLimited
Product evidenceStrong
PricingStrong
Market fitStrong
Best for
Dental practices seeking cloud-based radiograph interpretation and visual patient communication.
Pricing
R$ 130/mês
What to verify
Condition-level accuracy, validation studies and named deployments are not supplied; subscription limits are unspecified.
AI platform that automates CT scan analysis for oncology care, streamlining clinical workflows across three critical areas: body composition and sarcopenia assessment, tumor les...
Why #3
74/100 evidence score
Automates lesion sizing, RECIST target classification and sarcopenia assessment. The company reports working with Stanford Hospital, Cedars-Sinai, UCI Health and Weill Cornell.
DescriptionPrimary Use Cases
Task fitStrong
Adoption evidenceModerate
Product evidenceStrong
PricingLimited
Market fitStrong
Best for
Oncology teams standardizing CT measurements and RECIST workflows.
Pricing
Pricing not published
What to verify
Hospital relationship roles and deployment scale are unspecified; pricing, regulatory status and clinical validation are not supplied.
An AI-powered spine MRI analysis suite that integrates with PACS/RIS systems to automate measurements, segment anatomical structures, detect pathologies, and assist in report ge...
Why #4
72/100 evidence score
Segments anatomy, detects pathologies and automates measurements with PACS/RIS integration. FDA clearance and a $0 free plan are listed.
DescriptionPrimary Use CasesComplianceFree Plan Or Trial
Task fitStrong
Adoption evidenceLimited
Product evidenceStrong
PricingModerate
Market fitStrong
Best for
Radiology teams automating spine-MRI measurements and pathology detection.
Pricing
$0/mo
What to verify
Paid-tier prices, free-plan limits, cleared indications and real-world deployment evidence are unspecified.
An AI-based software suite designed for Neuro MRI that provides real-time detection of critical findings, intelligent protocol adaptation, and scan prioritization.
Why #6
64/100 evidence score
Detects critical brain-MRI findings in real time and combines analysis with adaptive protocols and reading prioritization; medical-device compliance is listed.
DescriptionPrimary Use CasesCompliancePricing
Task fitStrong
Adoption evidenceLimited
Product evidenceStrong
PricingLimited
Market fitStrong
Best for
Neuro-MRI teams needing in-scan finding detection and protocol adaptation.
Pricing
Enterprise Custom
What to verify
Enterprise pricing has no disclosed amount; detection performance and clinical deployments are not supplied.
AI-powered chest X-ray analysis software for detecting 10 major chest radiologic findings as an adjunctive tool for interpreting physicians.
Why #8
64/100 evidence score
Purpose-built adjunctive software detects ten major chest radiologic findings. Supplied compliance evidence lists FDA clearance, CE marking and MFDS approval.
AI-powered solution for prostate cancer detection and grading; CE marked under IVDR for First Read.
Why #9
63/100 evidence score
Directly detects and grades prostate cancer, with explicitly matched IVDR CE-marking evidence for First Read rather than only general platform compliance.
DescriptionPrimary Use CasesComplianceSocial Following
Task fitStrong
Adoption evidenceLimited
Product evidenceStrong
PricingLimited
Market fitStrong
Best for
Digital pathology laboratories seeking prostate cancer detection and grading.
Pricing
Pricing not published
What to verify
Pricing, named clinical deployments and comparative validation results are not supplied.
AI decision-support solution for chest X-rays; detects up to 124 findings in under 20 seconds; shown to improve accuracy by 45% averaged across analyzed findings.
Why #10
63/100 evidence score
The supplied description specifies detection of up to 124 findings in under 20 seconds, alongside EU MDR Class IIb certification.
DescriptionPrimary Use CasesCompliance
Task fitStrong
Adoption evidenceLimited
Product evidenceStrong
PricingLimited
Market fitStrong
Best for
Broad chest-X-ray finding detection for radiologist review.
Pricing
Pricing not published
What to verify
The reported 45% average accuracy improvement lacks study details; pricing and deployment proof are absent.
